PATENT CLAIM ANALYSIS

Application Number: 16116065
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "217000"]

Abstract:
Described herein are IRE1α inhibitors, compositions containing such inhibitors, and methods of treatment that include administration of such compounds. Exemplary compounds are provided throughout the application.

Claim (Index 14):
The compound of  claim 1 , wherein D is selected from the group consisting of:

Metadata:
- Claim Count in Document: 4.0
- Percentile: 96.0
- Lexical Diversity: 1.30435
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15449547', '13697743', '15506380', '14428546', '12892351']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7985966754864796
- 35 USC 102 Novelty (BERT): 0.5056284681022752
- Combined Prediction Score: 0.7692998547480592
- Mean Citation Score: 233.41375
- Max Citation Score: 289.48477
- Similarity Product: 233.38735729544285

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test